May 2020 – Maritime Health Trainings for Seafarers and Doctors

7 Dangerous Diseases/Disorders Seafarers Should Be Aware Of

7 Dangerous Diseases/Disorders Seafarers Should Be Aware Of

https://safety4sea.com/eu-maritime-industry-calls-for-a-common-approach-on-safety-of-transport-workers/

Interim guidance for use of the Bharat BBV152 Covaxin vaccine published November 3, 2021
The interim recommendations for use of the Bharat BBV152 Covaxin vaccine have been published.Bharat BBV152 Covaxin interim recommendations
WHO issues emergency use listing for eighth COVID-19 vaccine November 3, 2021
Today, the World Health Organization (WHO) issued an emergency use listing (EUL) for COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of COVID-19 caused by SARS-CoV-2.WHO’s EUL procedure assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX vaccine supply. […]
Urgent need for vaccine to prevent deadly Group B streptococcus November 1, 2021
A new report from the World Health Organization (WHO) and the London School of Hygiene & Tropical Medicine (LSHTM) reveals the alarming global impact of Group B streptococcus (GBS) – a common bacterium that can be transmitted in the womb, during birth, or in the early weeks of life – leading to around 150,000 deaths […]

Assessment of the further spread and potential impact of the SARS-CoV-2 Omicron variant of concern in the EU/EEA, 19th update January 27, 2022
The SARS-CoV-2 Omicron variant of concern (VOC) is rapidly replacing SARS-CoV-2 Delta in most European Union/European Economic Area (EU/EEA) countries, and is broadly following a west-to-east progression.
Assessment of the further emergence of the SARS-CoV-2 Omicron VOC in the context of the ongoing Delta VOC transmission in the EU/EEA, 18th update December 15, 2021
The risk to public health posed by the spread of the Omicron VOC in the context of ongoing Delta VOC transmission in the EU/EEA is assessed in this update.
Threat Assessment Brief: Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA - first update December 2, 2021
The number of countries reporting SARS-CoV-2 Omicron variant of concern (VOC) cases continues to increase globally, with a total of 352 confirmed cases reported by 27 countries as of 16.00 on 1 December 2021, including 70 confirmed cases reported by 13 European Union and European Economic Area (EU/EEA) countries.